1 unknown, 1 withdrawn. 2 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Unknown 1, Withdrawn 1 |
| Phase 3 | 1 | Withdrawn 1 |
Follow Chronic Hypertension: new trials by email Literature Review of Chronic Hypertension trials Research Report on Chronic Hypertension
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Spironolactone in CKD Enabled by Chlorthalidone: PILOT Spironolactone, Chlorthalidone, Placebo - Renal Insufficiency, Chronic Hypertension | Phase 2 | Unknown | Indiana Institute for Medical Research | 24 | 2022-02-01 | 2023-08-14 |
| Labetalol Versus Magnesium Sulfate (MgSO4) for the Prevention of Eclampsia Trial labetalol (seizure prevention), MgSO4 (seizure prevention) - Preeclampsia, Pregnancy Induced Hypertension | Phase 2 / Phase 3 | Withdrawn | Baylor College of Medicine | 2015-06-01 | 2017-01-13 |
Hypertension (2) · Eclampsia (1) · HELLP Syndrome (1) · Hypertension, Pregnancy-Induced (1) · Pre-Eclampsia (1) · Renal Insufficiency (1) · Renal Insufficiency, Chronic (1) · Seizures (1)
Cardiovascular Diseases (2) · Female Urogenital Diseases and Pregnancy Complications (2) · Pathological Conditions, Signs and Symptoms (2) · Urogenital Diseases (2) · Vascular Diseases (2) · Chronic Disease (1) · Disease Attributes (1) · Female Urogenital Diseases (1) · Kidney Diseases (1) · Male Urogenital Diseases (1) · Nervous System Diseases (1) · Neurologic Manifestations (1) · Pathologic Processes (1) · Pregnancy Complications (1) · Signs and Symptoms (1)
Chlorthalidone (1) · Labetalol (1) · Spironolactone (1)
Baylor College of Medicine (1) · Indiana Institute for Medical Research (1)
United States (2) · India (1)
Michael A Belfort, MD, PhD (1) · Rajiv Agarwal, MD (1)